Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

A correction has been published 1

Review ArticleMechanisms of Disease

Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine

List of authors.
  • Jeffrey Lefkovits, M.B., B.S.,
  • Edward F. Plow, Ph.D.,
  • and Eric J. Topol, M.D.

Platelets have a key role in atherosclerosis, thrombosis, and acute coronary syndromes. Therapeutic manipulation of platelet function has focused principally on the use of aspirin, which has proved effective in many clinical situations, despite its relatively weak antiplatelet action. More recently, the platelet glycoprotein IIb/IIIa receptor has been identified as the pivotal mediator of platelet aggregation, making it a logical target for control of the platelet response to vascular injury. This review summarizes the current state of knowledge of the biology of glycoprotein IIb/IIIa receptors and examines the development of agents that inhibit these receptors — a diverse group of . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Author Affiliations

From the Department of Cardiology and the Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Cleveland Clinic Foundation, Cleveland.

Address reprint requests to Dr. Topol at the Department of Cardiology, One Clinic Center, Cleveland Clinic Foundation, Cleveland, OH 44195.

Print Subscriber? Activate your online access.